Neumega and Chest pain - a phase IV clinical study of FDA data

Summary:

Chest pain is reported as a side effect among people who take Neumega (oprelvekin), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Neupogen, and have Hepatitis c.

The phase IV clinical study analyzes which people have Chest pain when taking Neumega. It is created by eHealthMe based on reports of 818 people who have side effects when taking Neumega from the FDA, and is updated regularly.

What is Neumega?

Neumega has active ingredients of oprelvekin. eHealthMe is studying from 822 Neumega users. Check the latest studies of Neumega.

What is Chest pain?

Chest pain is found to be associated with 3,459 drugs and 4,889 conditions by eHealthMe. Check the latest studies of Chest pain.

On Aug, 12, 2026

818 people reported to have side effects when taking Neumega.
Among them, 51 people (6.23%) have Chest pain.

Among these 51 people:

How long have people been on Neumega when they have Chest pain? *

What is the gender of people who have Chest pain when taking Neumega? *

female: 29.41 %
male: 70.59 %

What is the age of people who have Chest pain when taking Neumega? *

What are other drugs people take besides Neumega? *

What are other side effects people have besides Chest pain? *

Hypoaesthesia (reduced sense of touch or sensation): 20 people, 39.22%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 19 people, 37.25%
Joint Pain: 18 people, 35.29%
Thrombocytopenia (decrease of platelets in blood): 16 people, 31.37%
Abdominal Pain: 14 people, 27.45%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 14 people, 27.45%
Back Pain: 14 people, 27.45%
Gait Disturbance: 14 people, 27.45%
Osteonecrosis Of Jaw (death of bone of jaw): 13 people, 25.49%
Pleural Effusion (water on the lungs): 13 people, 25.49%

What are the existing conditions these people have? *

Hepatitis C: 6 people, 11.76%
Thrombocytopenia (decrease of platelets in blood): 3 people, 5.88%
Red Blood Cell Count Decreased: 2 people, 3.92%
Red Blood Cell Abnormality (abnormal red blood cells): 2 people, 3.92%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 1 person, 1.96%
Pain In Extremity: 1 person, 1.96%
Metastases To Liver (cancer spreads to liver): 1 person, 1.96%
High Blood Cholesterol: 1 person, 1.96%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 1.96%
Depression: 1 person, 1.96%

* Approximation only. Some reports may have incomplete information.

Do you take Neumega and have Chest pain?

- Check whether Chest pain is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Neumega:

Neumega (822 reports)

Chest pain treatments and more:

Chest pain (363,501 reports)

Browse all side effects of Neumega:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Chest pain:

Chest pain (3,459 drugs)

Browse all the conditions that are associated with Chest pain:

Chest pain (4,889 conditions)

Related publications that referenced our studies

Pang, T., & Gudi, A., "Chest pain following the use of fluvoxamine in depression", Proceedings of Singapore Healthcare, 2018 Jan .
Pang, T., & Gudi, A., "Chest pain following the use of fluvoxamine in depression", Proceedings of Singapore Healthcare, 2018 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on oprelvekin (the active ingredients of Neumega) and Neumega (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.